検索結果

Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente...

Meetings of the Minds | Research & Development | SENJU Pharmaceutica

開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...

CEO Message | About Senju | SENJU Pharmaceutical

on the scale and sales of a Big Company, but rather to pursue the happiness of everyone associated with Senju and continue to be a “Good Company” as a management principle. To do this, we engage in “...

pan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed...

pan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed...